SCHEMBL4894571

SCHEMBL4894571

Cc1cc(-c2ccc(-c3ccccc3)cc2)nn1CCOc1ccc(CCC(=O)O)c(CNCC(=O)OC(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 17/20 0.51
PPARA Q07869 16/20 0.51
MAPT P10636 1/20 0.37
PPARD Q03181 4/20 0.37
CSF3R Q99062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897375 0.98 PPARG (0.50) PPARGPPARAPPARD
SCHEMBL4887413 0.93 PPARG (0.44) PPARGPPARAPPARDCSF3R
SCHEMBL4894333 0.89 PPARG (0.65) PPARGPPARAPPARDCSF3R
SCHEMBL4887727 0.87 PPARG (0.64) PPARGPPARAPPARD
SCHEMBL4894563 0.84 PPARG (0.47) PPARGPPARAPPARD
SCHEMBL4885618 0.84 PPARG (0.57) PPARGPPARAPPARDCSF3R
SCHEMBL4897422 0.83 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL14111235 0.83 PPARG (0.57) PPARGPPARAPPARDCSF3R
SCHEMBL4891066 0.83 PPARG (0.59) PPARGPPARAPPARD
SCHEMBL4893585 0.83 PPARG (0.57) PPARGPPARACSF3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) GOSSETT LYNN STACY 2008-07-10 US disclosed
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US disclosed
EP-1401434-B1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) LILLY CO ELI (US) 2006-11-15 EP disclosed
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) ELI LILLY AND COMPANY 2005-04-07 US disclosed
EP-1401434-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) ELI LILLY AND COMPANY (US) 2004-03-31 EP disclosed
WO-2002100403-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) ELI LILLY AND COMPANY (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885MAPT 2702/4885
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885MAPT 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.